Published in Blood Weekly, November 30th, 2006
Ron Gelbman, a Haemonetics board member since 2000, was elected lead director, effective immediately.
Matricaria had been a Haemonetics director since October 2002, and chairman since April 2003.
Matricaria said, "During the past 4 years Haemonetics made remarkable progress in preparing to transition into a higher-growth profile company. That transformation is now well underway. I am proud of my association...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.